Earnings per Share |
Note 16 — Earnings per Share
The following table is a reconciliation of the components used to derive basic and diluted EPS for the periods indicated:
|
|
|
|
|
|
Weighted-
|
|
|
|
|
|
|
|
Net
|
|
|
Average
|
|
|
Per
|
|
|
|
Income
|
|
|
Shares
|
|
|
Share
|
|
|
|
(Numerator)
|
|
|
(Denominator)
|
|
|
Amount (1)
|
|
Year Ended December 31, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
98,677
|
|
|
|
30,393,559
|
|
|
$
|
3.25
|
|
Less: income allocated to unvested restricted stock
|
|
|
671
|
|
|
|
30,393,559
|
|
|
|
0.02
|
|
Basic EPS
|
|
$
|
98,006
|
|
|
|
30,393,559
|
|
|
$
|
3.22
|
|
Effect of dilutive securities - options and unvested restricted stock
|
|
|
—
|
|
|
|
78,188
|
|
|
|
—
|
|
Diluted EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
98,677
|
|
|
|
30,471,747
|
|
|
$
|
3.24
|
|
Less: income allocated to unvested restricted stock
|
|
|
671
|
|
|
|
30,471,747
|
|
|
|
0.02
|
|
Diluted EPS
|
|
$
|
98,006
|
|
|
|
30,471,747
|
|
|
$
|
3.22
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2020
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
42,196
|
|
|
|
30,280,415
|
|
|
$
|
1.39
|
|
Less: income allocated to unvested restricted stock
|
|
|
532
|
|
|
|
30,280,415
|
|
|
|
0.02
|
|
Basic EPS
|
|
$
|
41,664
|
|
|
|
30,280,415
|
|
|
$
|
1.38
|
|
Effect of dilutive securities - options and unvested restricted stock
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Diluted EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
42,196
|
|
|
|
30,280,415
|
|
|
$
|
1.39
|
|
Less: income allocated to unvested restricted stock
|
|
|
532
|
|
|
|
30,280,415
|
|
|
|
0.02
|
|
Diluted EPS
|
|
$
|
41,664
|
|
|
|
30,280,415
|
|
|
$
|
1.38
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
32,788
|
|
|
|
30,725,376
|
|
|
$
|
1.07
|
|
Less: income allocated to unvested restricted stock
|
|
|
230
|
|
|
|
30,725,376
|
|
|
|
0.01
|
|
Basic EPS
|
|
$
|
32,558
|
|
|
|
30,725,376
|
|
|
$
|
1.06
|
|
Effect of dilutive securities - options and unvested restricted stock
|
|
|
—
|
|
|
|
35,046
|
|
|
|
—
|
|
Diluted EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
32,788
|
|
|
|
30,760,422
|
|
|
$
|
1.07
|
|
Less: income allocated to unvested restricted stock
|
|
|
230
|
|
|
|
30,760,422
|
|
|
|
0.01
|
|
Diluted EPS
|
|
$
|
32,558
|
|
|
|
30,760,422
|
|
|
$
|
1.06
|
|
(1)
|
Per share amounts may not be able to be recalculated using net income and weighted-average shares presented above due to rounding.
|
There were no anti-dilutive options outstanding for the years ended December 31, 2021, 2020 and 2019.
|